The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia.

TitleErythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia.
Publication TypeJournal Article
Year of Publication2004
AuthorsSpandou, E., Soubasi V., Papoutsopoulou S., Karkavelas G., Simeonidou C., Kaiki-Astara A., & Guiba-Tziampiri O.
JournalNeurosci Lett
Volume366
Issue1
Pagination24-8
Date Published2004 Aug 05
ISSN0304-3940
KeywordsAnimals, Animals, Newborn, Asphyxia Neonatorum, Brain, Disease Models, Animal, DNA Fragmentation, Erythropoietin, Female, Humans, Hypoxia-Ischemia, Brain, Infant, Newborn, Male, Neuroprotective Agents, Rats, Rats, Wistar, Reflex
Abstract

Erythropoietin (EPO) prevents neuronal damage following ischemic, metabolic and excitotoxic stress. Recent studies have shown that EPO plays a significant role in the developing brain. The present study investigates the effect of EPO administration on hypoxic-ischemic brain injury and the possibility that its neuroprotective action may be associated with anti-apoptotic activity. Seven-day-old rats were treated with EPO (2000 U/kg) and subjected to a modified Levine procedure. EPO administration before the hypoxic-ischemic insult significantly reduces the severity of brain damage and improved the short-term functional brain recovery. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and DNA electrophoresis displayed no evidence of DNA fragmentation in EPO-treated animals. These results suggest that EPO might protect the neonatal rat brain by anti-apoptotic mechanisms.

DOI10.1016/j.neulet.2004.05.032
Alternate JournalNeurosci Lett
PubMed ID15265583

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.